Subscribe
Healthcare

Neuralink approved by FDA for brain implant trial on humans

By Gabrielle M. Etzel
Published
Add Washington Examiner on Google
Neuralink approved by FDA for brain implant trial on humans


Neuralink, Elon Musk’s brain implant company, announced Thursday night that its first human trial has been approved by the Food and Drug Administration.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Elon Musk FDA